News - LGC, an international leader in the life sciences tools sector, is playing an active role in the global response to COVID-19
08 April 2020News - Offers expanded genome coverage to include S gene region
07 May 2020News - Solutions address critical need for clinical laboratories to be able to report antibody testing results with confidence
28 May 2020News - Aims to refine testing approaches, stratify treatment options, determine isolation requirements and speed up measurement
28 May 2020News - Panel demonstrates a range of SARS-CoV-2 antibody reactivity
19 June 2020News - Research programme brings together experts who are highly experienced in evaluating diagnostic tests and generating robust evidence required for a test to be used in the NHS
24 June 2020News - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma
09 July 2020News - Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features
15 July 2020News - M4R will run until the end of 2020 and will enable businesses to have access to the world-leading chemical and bio-measurement expertise and capabilities at the NML.
27 August 2020News - First commercially cvailable SARS-CoV-2 antibody test in UK compatible with Neoteryx’s Mitra® Microsampling Device for at-home blood collection
23 September 2020